Close
Novotech
Jabsco PureFlo 21 Single Use
Production & ManufacturingWhite Papers

4 Trends Transforming the Never-Normal Future of Manufacturing

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

BioPharma

Gene Expression Systems Explained for Biotech Founders

Choosing a gene expression system is one of the earliest and most consequential manufacturing decisions a biotech founder will make yet it is often made without fully understanding what is at stake. This article breaks down the key expression platforms used in biologic drug development, what differentiates them technically and commercially, and why the choice you make now will follow your program all the way to the clinic and beyond.
Business & Industry

AbbVie to Invest $1.4B in North Carolina Manufacturing Plant

AbbVie has outlined plans to build a major new...
Business & Industry

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

AbbVie has entered into a global licensing agreement with...
- Advertisement -

2021 Manufacturing Trends
If 2020 was the year of disruption, 2021 is the year of adaptation. Download this trend brief to explore ways that manufacturers are adapting to change and evolving to stay competitive.

What’s Included:
  • Embracing digitization.
  • Liberating data.
  • Balancing supply chains.
  • Empowering workers. 

Click Here To Download The Whitepaper

Latest stories

Previous article
Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper
Next article
Recipharm secures vaccine manufacturing deal

Related stories

BioPharma

Gene Expression Systems Explained for Biotech Founders

Choosing a gene expression system is one of the earliest and most consequential manufacturing decisions a biotech founder will make yet it is often made without fully understanding what is at stake. This article breaks down the key expression platforms used in biologic drug development, what differentiates them technically and commercially, and why the choice you make now will follow your program all the way to the clinic and beyond.
Business & Industry

AbbVie to Invest $1.4B in North Carolina Manufacturing Plant

AbbVie has outlined plans to build a major new...
Business & Industry

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

AbbVie has entered into a global licensing agreement with...
Business & Industry

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Danish pharmaceutical major Novo Nordisk has entered into a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
MSD Google Cloud Partnership

MSD Google Cloud Partnership Drives AI Adoption at Scale

Gene Expression system biologics drug development platform selection

Gene Expression Systems Explained for Biotech Founders